Twist Bioscience Corporation

TWST

Biotech & pharmaceuticalsGenomic analysis

$139.73vs prev close▼-5.86(-4.03%)

$23.3052W Range$145.93

95% from low

+49.59 (+54.94%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

10 sells

Consecutive sells

1M net buy

-$29.4M

≈ -239K shares

Portfolio Weight

3.11%

1M +0.32%p

Holding ETFs

2 ETFs

ARKG · ARKK

Price Effect (Sell)

Shares decreased, but price appreciation increased portfolio weight.

Shares -12.7% · Market value +0.5% · Weight +0.32%p

Trade Intensity

Concentrated sells

Basis: 9 sells · 1 buys in 1M · Multi-ETF simultaneous sell · weight +0.32%p increase

Trade Log7-day SELL streak

Date	Action	ETF	Shares	Close	Est. total
26.08.19	SELL	ARKK	75,445	$142.39	$10.7M
26.08.17	SELL	ARKG · ARKK	63,297	$124.41	$7.9M
26.08.14	SELL	ARKK	1,183	$118.57	$140.3K
26.08.13	SELL	ARKK	11,552	$125.29	$1.4M
26.08.12	SELL	ARKG · ARKK	47,842	$125.21	$6.0M
26.08.11	SELL	ARKG · ARKK	9,789	$123.12	$1.2M
26.08.10	SELL	ARKG	3,418	$124.88	$426.8K
26.08.05	BUY	ARKG · ARKK	26,732	$115.01	$3.1M
26.07.29	SELL	ARKK	13,516	$85.47	$1.2M
26.07.28	SELL	ARKK	39,594	$88.55	$3.5M
26.07.23	SELL	ARKK	45,713	$92.44	$4.2M
26.07.17	SELL	ARKG · ARKK	8,441	$93.85	$792.2K
26.07.16	SELL	ARKG · ARKK	9,146	$91.23	$834.4K
26.07.15	SELL	ARKG · ARKK	71,209	$92.61	$6.6M
26.07.14	SELL	ARKG · ARKK	35,289	$92.53	$3.3M

08.19SELL

75,445

ARKKClose$142.39Est. total$10.7M

08.17SELL

63,297

ARKG · ARKKClose$124.41Est. total$7.9M

08.14SELL

1,183

ARKKClose$118.57Est. total$140.3K

08.13SELL

11,552

ARKKClose$125.29Est. total$1.4M

08.12SELL

47,842

ARKG · ARKKClose$125.21Est. total$6.0M

08.11SELL

9,789

ARKG · ARKKClose$123.12Est. total$1.2M

08.10SELL

3,418

ARKGClose$124.88Est. total$426.8K

08.05BUY

26,732

ARKG · ARKKClose$115.01Est. total$3.1M

07.29SELL

13,516

ARKKClose$85.47Est. total$1.2M

07.28SELL

39,594

ARKKClose$88.55Est. total$3.5M

07.23SELL

45,713

ARKKClose$92.44Est. total$4.2M

07.17SELL

8,441

ARKG · ARKKClose$93.85Est. total$792.2K

07.16SELL

9,146

ARKG · ARKKClose$91.23Est. total$834.4K

07.15SELL

71,209

ARKG · ARKKClose$92.61Est. total$6.6M

07.14SELL

35,289

ARKG · ARKKClose$92.53Est. total$3.3M

1 / 11

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

3,346,305

Portfolio Weight

3.11%

in ETF 9.13%

Est. Value

$385M

30D Net

-$61M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Strong Buy

Buy

Hold

Analyst Targets

avg.

$105.30

vs Current ▼ -27.7% downside

Current$145.59

Low ~ High$36.00 ~ $120.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Piper Sandler

Overweight

$115.00

-21.01%

—

Maintain

2026-08-05

Baird

Outperform

$115.00

-21.01%

—

Maintain

2026-08-04

Canaccord Genuity

Buy

$120.00

-17.58%

—

Maintain

2026-07-14

Evercore ISI Group

In-Line

$102.00

-29.94%

—

Downgrade

2026-07-06

Guggenheim

Buy

$107.00

-26.51%

—

Maintain

2026-06-29

1 / 4

Avg Target

$105.30

vs Current ▼ -27.7% downside

Buy

11 analysts

Strong Buy 2Buy 7Hold 2

Low $36.00

Current $145.59

High $120.00

Firm	Position	Target	Upside	Close	Action	Date
Piper Sandler	Overweight	$115.00	-21.01%	—	Maintain	26.08.05
Baird	Outperform	$115.00	-21.01%	—	Maintain	26.08.04
Canaccord Genuity	Buy	$120.00	-17.58%	—	Maintain	26.07.14
Evercore ISI Group	In-Line	$102.00	-29.94%	—	Downgrade	26.07.06
Guggenheim	Buy	$107.00	-26.51%	—	Maintain	26.06.29

1 / 4

Price Information

Previous Close$136.33

Open$138.80

Day Range$135.11 - $145.93

52-Week Range$23.30 - $145.93

1-Year Change431.54%

Trading Volume

Volume1,793,489

Avg Volume (3mo)1,808,412

Valuation

Market Cap9.1B

Book Value$7.11

Shares Outstanding62,707,424

Financials

Revenue (TTM)431.8M

Net Income-136,716,992

EPS$-2.23

EBITDA-115,282,000

Profitability

P/E Ratio-

P/B Ratio20.47

Return on Equity (ROE)-29.59%

Return on Assets (ROA)-13.09%

Profit Margin-31.66%

EV/EBITDA-78.69

Beta2.16

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)71.14

Company Overview

Twist Bioscience Corporation is a leading manufacturer of synthetic DNA, offering a wide range of DNA-based products and services. Their offerings include synthetic genes, oligo pools, and NGS tools used across various industries like therapeutics, diagnostics, and research. The company is positioned as a key enabler of innovation in biotechnology and life sciences through its DNA synthesis platform.

P/B

20.47

High valuation

ROE

-29.6%

Persistent loss

Beta

2.16

Extreme volatility

RSI(14)

71.1

Overbought

AI-generated summary. Not investment advice.

Twist Bioscience Corporation

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks